These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27471168)

  • 1. Restoration of intestinal function in an MPTP model of Parkinson's Disease.
    Ellett LJ; Hung LW; Munckton R; Sherratt NA; Culvenor J; Grubman A; Furness JB; White AR; Finkelstein DI; Barnham KJ; Lawson VA
    Sci Rep; 2016 Jul; 6():30269. PubMed ID: 27471168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm).
    Cheng L; Quek CY; Hung LW; Sharples RA; Sherratt NA; Barnham KJ; Hill AF
    Sci Rep; 2016 Mar; 6():22398. PubMed ID: 26928495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL; Qu R; Zhang J; Li LF; Ma SP
    Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
    Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D
    J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor.
    Kang KH; Liou HH; Hour MJ; Liou HC; Fu WM
    Neuropharmacology; 2013 Oct; 73():380-7. PubMed ID: 23800665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
    Verhave PS; Jongsma MJ; Van Den Berg RM; Vanwersch RA; Smit AB; Philippens IH
    Neuropharmacology; 2012 Mar; 62(4):1700-7. PubMed ID: 22178201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor.
    Sun X; Xiong Z; Zhang Y; Meng Y; Xu G; Xia Z; Li J; Zhang R; Ke Z; Xia Z; Hu Y
    J Neurochem; 2012 Mar; 120(6):1072-83. PubMed ID: 22192054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Moore C; Meshul CK
    Neuroscience; 2015 Apr; 290():454-71. PubMed ID: 25655214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
    Watanabe Y; Himeda T; Araki T
    Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease.
    Laloux C; Petrault M; Lecointe C; Devos D; Bordet R
    Pharmacol Res; 2012 May; 65(5):514-22. PubMed ID: 22391246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
    Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
    J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.
    Wang Q; Shin EJ; Nguyen XK; Li Q; Bach JH; Bing G; Kim WK; Kim HC; Hong JS
    J Neuroinflammation; 2012 Jun; 9():124. PubMed ID: 22695044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.